v3.26.1
Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Schedule of Intangible Assets [Line Items]    
Total intangible assets, net $ 48,670,775 $ 2,299,554
Non-Exclusive License Agreement [Member]    
Schedule of Intangible Assets [Line Items]    
Total intangible assets, net 179,821 179,821
Various generic drugs [Member]    
Schedule of Intangible Assets [Line Items]    
Total intangible assets, net 736,983
Four generic drugs (Encore) [Member]    
Schedule of Intangible Assets [Line Items]    
Total intangible assets, net 1,308,270
Needleless Syringe License [Member]    
Schedule of Intangible Assets [Line Items]    
Total intangible assets, net 26,060 26,060
Patents [Member]    
Schedule of Intangible Assets [Line Items]    
Total intangible assets, net 48,420 48,420
Mineral rights and exploratory [Member]    
Schedule of Intangible Assets [Line Items]    
Total intangible assets, net $ 48,416,474